phosphoric acid mono-(4-allyl-2-methoxy-phenyl ester) | 162888-26-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磷酸及其衍生物
• 英文名称: phosphoric acid mono-(4-allyl-2-methoxy-phenyl ester)
• 英文别名: Phosphorsaeure-mono-(2-methoxy-4-allyl-phenylester)；Phosphorsaeure-mono-(4-allyl-2-methoxy-phenylester)；Eugenolphosphorsaeure；Eugenol phosphate；(2-methoxy-4-prop-2-enylphenyl) dihydrogen phosphate
• CAS: 162888-26-8
• 化学式: C₁₀H₁₃O₅P
• 分子量: 244.184
• InChiKey: BZOCGHBKNGXWSL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  76
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  phosphoric acid mono-(4-allyl-2-methoxy-phenyl ester) 在 氢氧化钾 作用下， 生成 phosphoric acid mono-(2-methoxy-4-propenyl-phenyl ester)
  参考文献：
  名称：

  DE98522

  摘要：

  公开号：
• 作为产物：
  描述：

  丁香酚 在 三氯氧磷 作用下， 生成 phosphoric acid mono-(4-allyl-2-methoxy-phenyl ester)
  参考文献：
  名称：

  DE98522

  摘要：

  公开号：

文献信息

• Inhibiting undesirable taste in oral compositions
  申请人：THE PROCTER & GAMBLE COMPANY

  公开号：EP0845217A1

  公开（公告）日：1998-06-03

  The present invention relates to a method for inhibiting an undesirable taste in oral compositions such as foods, beverages, dental compositions, and pharmaceuticals. The present invention also relates to oral and pharmaceutical compositions comprising undesirable tasting compounds wherein undesirable tastes are inhibited by the addition of an inhibitor of intracellular phosphatase enzymes of taste cells to said oral and pharmaceutical compositions. Said inhibitor is selected from phosphates, thiophosphates, phosphonates, vanadates, bisphosphates, bisphosphonates, phosphate-phosphonates, thiophosphate-phosphates, thiophosphate-phosphonates, their physiologically-relevant salts and esters, and mixtures thereof.

  本发明涉及一种抑制口服组合物（如食品、饮料、牙科组合物和药物）中不良味道的方法。本发明还涉及包含不良味道化合物的口服和药物组合物，其中通过在所述口服和药物组合物中添加味觉细胞内磷酸酶抑制剂来抑制不良味道。所述抑制剂选自磷酸盐、硫代磷酸盐、膦酸盐、钒酸盐、双磷酸盐、双膦酸盐、磷酸盐-膦酸盐、硫代磷酸盐-磷酸盐、硫代磷酸盐-膦酸盐、它们的生理相关盐和酯，以及它们的混合物。
• Antibody-nanoparticle conjugates and methods for making and using such conjugates
  申请人：Ventana Medical Systems, Inc.

  公开号：US10031134B2

  公开（公告）日：2018-07-24

  Disclosed herein are antibody-nanoparticle conjugates that include two or more nanoparticles (such as gold, palladium, platinum, silver, copper, nickel, cobalt, iridium, or an alloy of two or more thereof) directly linked to an antibody or fragment thereof through a metal-thiol bond. Methods of making the antibody-nanoparticle conjugates disclosed herein include reacting an arylphosphine-nanoparticle composite with a reduced antibody to produce an antibody-nanoparticle conjugate. Also disclosed herein are methods for detecting a target molecule in a sample that include using an antibody-nanoparticle conjugate (such as the antibody-nanoparticle conjugates described herein) and kits for detecting target molecules utilizing the methods disclosed herein.

  本文公开的抗体-纳米颗粒共轭物包括两个或两个以上的纳米颗粒（如金、钯、铂、银、铜、镍、钴、铱或两个或两个以上的合金）通过金属-硫醇键与抗体或其片段直接连接。本文公开的抗体-纳米粒子共轭物的制造方法包括将芳基膦-纳米粒子复合体与还原抗体反应，生成抗体-纳米粒子共轭物。本文还公开了检测样品中目标分子的方法，包括使用抗体-纳米粒子共轭物（如本文所述的抗体-纳米粒子共轭物）和利用本文公开的方法检测目标分子的试剂盒。
• Oral products having an aesthetic layer
  申请人：The Procter & GambleCompany

  公开号：US20040057910A1

  公开（公告）日：2004-03-25

  A packaged tooth whitening product is provided. The package includes a substrate having a first side and a second side, wherein the substrate is sized for use in a human user's oral cavity. A first composition including a tooth whitening agent is disposed adjacent the first side of the substrate. A second composition including an aesthetic agent disposed adjacent the second side of the substrate.

  提供了一种包装牙齿美白产品。包装包括具有第一面和第二面的基底，其中基底的大小用于人类使用者的口腔。包括牙齿美白剂的第一种组合物放置在基底的第一面附近。第二种组合物包括一种美白剂，与基底的第二面相邻。
• Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
  申请人：Bieniarz Christopher

  公开号：US20050100976A1

  公开（公告）日：2005-05-12

  The invention is directed to enhanced methods for detecting an analyte of interest in situ, by immunoassay, or by hybridization comprising binding an enzyme-labeled conjugate molecule to an analyte of interest in the presence of a redox-inactive reductive species and a soluble metal ion. The enzyme catalyzes the conversion of the inactive reductive species to an active reducing agent, which in turn reduces the metal ion to a metal atom thereby providing an enhanced means of detecting the analyte via metal deposition.

  本发明涉及原位、免疫测定或杂交法检测有关分析物的增强方法，包括在氧化还原活性还原 物和可溶性金属离子存在的情况下，将酶标记的共轭分子与有关分析物结合。酶催化无活性还原物转化为活性还原剂，活性还原剂又将金属离子还原为金属原子，从而提供了一种通过金属沉积检测分析物的增强方法。
• Thuong,N.T.; Chabrier,P., Bulletin de la Societe Chimique de France, 1975, p. 2083 - 2088
  作者：Thuong,N.T.、Chabrier,P.

  DOI：——

  日期：——